Next Financial Group’s Oncolytics Biotech ONCY Stock Holding History

Next Financial Group’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$12K	Hold	8,550	–	–	﹤0.01%	2117
2021 Q3	$18K	Buy	8,550 +7,604	+804%	+$17.2K	﹤0.01%	1839
2021 Q2	$3K	Hold	946	–	–	﹤0.01%	2336
2021 Q1	$4K	Hold	946	–	–	﹤0.01%	2171
2020 Q4	$2K	Hold	946	–	–	﹤0.01%	2202
2020 Q3	$2K	Buy	+946	New	+$1.74K	﹤0.01%	2037
2020 Q2	–	Sell	-1,472	Closed	-$2K	–	1483
2020 Q1	$2K	Hold	1,472	–	–	﹤0.01%	1943
2019 Q4	$7K	Hold	1,472	–	–	﹤0.01%	1886
2019 Q3	$1K	Hold	1,472	–	–	﹤0.01%	2242
2019 Q2	$3K	Sell	1,472 -421	-22%	-$764	﹤0.01%	2033
2019 Q1	$4K	Hold	1,893	–	–	﹤0.01%	1318
2018 Q4	$3K	Hold	1,893	–	–	﹤0.01%	1687
2018 Q3	$7K	Buy	+1,893	New	+$8.79K	﹤0.01%	1098

Other funds holding ONCY

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $309M AUM 22.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Next Financial Group's ONCY Position: Q4 2021 in Review

Next Financial Group held its Oncolytics Biotech (ONCY) position steady in Q4 2021 at 8,550 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Next Financial Group first reported a position in ONCY in Q3 2018 and has held it in 13 quarters since. The position peaked at $18K in Q3 2021. 45 funds tracked by Wall St. Rank hold ONCY as of Q4 2021.

Next Financial Group held 8,550 shares of Oncolytics Biotech worth $12K as of Q4 2021.
Next Financial Group left its Oncolytics Biotech share count unchanged in Q4 2021.
Oncolytics Biotech made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2117 holding.
Next Financial Group first reported a position in Oncolytics Biotech in Q3 2018 and has held it in 13 quarters since.
Next Financial Group's Oncolytics Biotech position peaked at $18K in Q3 2021.
45 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.